
Electromed Authorizes New Share Repurchase Program
Electromed Authorizes $10 Million Share Repurchase Program to Strengthen Long-Term Shareholder Value Electromed, Inc. (NYSE American: ELMD), a recognized innovator in airway clearance therapy, announced on September 9, 2025, that its Board of Directors has authorized a new share repurchase…












